[REGN] YoY Quarter Result on 30-Jun-2017 [#Q2]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
03-Aug-2017
Financial Year
2017
Quarter
30-Jun-2017 [#Q2]
Profit Trend
QoQ- 55.76%
YoY- 97.61%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
Revenue 1,952,000 1,933,700 1,608,022 1,470,116 1,212,629 998,617 665,700 19.61%
PBT 918,900 224,700 656,074 525,850 292,256 327,996 203,119 28.57%
Tax 21,600 31,600 104,662 138,106 96,038 133,353 110,384 -23.78%
NP 897,300 193,100 551,412 387,744 196,218 194,643 92,735 45.92%
Tax Rate -2.35% -14.06% -15.95% -26.26% -32.86% -40.66% -54.34% -
Total Cost 1,054,700 1,740,600 1,056,610 1,082,372 1,016,411 803,974 572,965 10.69%
Ratio Analysis
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
NP Margin 45.97 9.99 34.29 26.38 16.18 19.49 13.93 21.99%
Per Share
30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 30/06/14 CAGR
EPS 8.19 1.77 5.12 3.66 1.88 1.89 0.96 42.89%
EPS Diluted 7.61 1.68 4.82 3.34 1.69 1.69 0.85 44.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.